Global Regulatory Affairs

This course will provide a comprehensive overview of US, European, Canadian, Japanese and Rest-of-World (ROW)/Emerging Market regulations for drug and biologic development from pre-clinical to post approval. Emphasis will be on FDA, European, and Canadian regulatory similarities and differences. Interactive sessions and workshops will identify and address regulatory obstacles faced by regulatory affairs professionals.